ArticleOphthalmology science2022

A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy.

Arshad M Khanani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.